The table below shows LIGAND PHARMACEUTICALS INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$51.72M
$115.46M
$47.63M
$45.33M
$51.81M
$41.53M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$2.15M
$21.02M
$6.57M
$50.09M
$5.67M
$5.35M
SG&A
LGND annual revenue (10-K history)
LIGAND PHARMACEUTICALS INC reported annual revenue of $268.09M for fiscal year 2025. That is up 60.4% from $167.13M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $108.97M (FY 2016) to $268.09M. Figures come from the company's audited annual reports as filed with the SEC.